News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

October 11, 2024
October 11, 2024
Categories

Journal of Clinical Oncology publishes RTOG 1106/ACRIN 6697 results: Midtreatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients

Do you like it?
Read more
October 11, 2024
October 11, 2024
Categories

Mid-treatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients: Results of NRG-RTOG1106/ECOG-ACRIN 6697

Do you like it?
Read more
October 10, 2024
October 10, 2024
Categories

Women in medicine month: celebrating women advancing radiology (mentions TMIST investigator Rita Freimanis, MD)

Do you like it?
Read more
September 26, 2024
September 26, 2024
Categories

The Fall 2024 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
September 20, 2024
September 20, 2024
Categories

The September 2024 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
September 18, 2024
September 18, 2024
Categories

Press Release: Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Do you like it?
Read more
September 10, 2024
September 10, 2024
Categories

Press Release: Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Do you like it?
Read more
September 6, 2024
September 6, 2024
Categories

Attention APPs: Travel funds are available for the Fall 2024 Group Meeting (apply now)

Do you like it?
Read more
September 5, 2024
September 5, 2024
Categories

Attention CRAs: Travel funds are available for the Fall 2024 Group Meeting (apply now)

Do you like it?
Read more
August 30, 2024
August 30, 2024
Categories

Registration is now open for the Fall 2024 Group Meeting

Do you like it?
Read more
August 30, 2024
August 30, 2024
Categories

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD Health Equity Travel Scholarship to attend the Fall 2024 Group Meeting

Do you like it?
Read more
August 29, 2024
August 29, 2024
Categories

How the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management

Do you like it?
Read more
August 28, 2024
August 28, 2024
Categories

Attention radiation oncologists and trainees: Travel funds are available for the Fall 2024 Group Meeting (apply now)

Do you like it?
Read more
August 21, 2024
August 21, 2024
Categories

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

Do you like it?
Read more
August 21, 2024
August 21, 2024
Categories

The implications of the E3311 trial in HPV+ head and neck cancer: Dr. Ranee Mehra

Do you like it?
Read more
August 20, 2024
August 20, 2024
Categories

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

Do you like it?
Read more
August 17, 2024
August 17, 2024
Categories

Nivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)

Do you like it?
Read more
August 14, 2024
August 14, 2024
Categories

The August 2024 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
August 1, 2024
August 1, 2024
Categories

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

Do you like it?
Read more
July 24, 2024
July 24, 2024
Categories

Press Release: New England Journal of Medicine publishes practice-changing E1910 trial results

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Breast cancer Cancer screening Cancer treatment Care delivery Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing Genomic testing GI cancer Group meeting Head and neck cancer Health equity Hogkin lymphoma Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma NCI-MATCH Non-Hodgkin lymphoma Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Skin cancer Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group